Lauren A Peters, PhD
Lauren Peters, M.A., Ph.D, is an Assistant Professor in the Department of Genetics and Genomic Sciences and a faculty member of the Icahn Genomics Institute. Dr. Peters was trained in immunology, genetics and computational biology. Her research focuses on the discovery of how rare and common genetic drivers of known immune mediated and as yet, unknown, immune drivers of other systemic and organ specific diseases, function in pathology. Her research is applied to the design of next generation in silico models of disease by the integration of clinical electronic medical record with multi-omics profiling of the disease tissue from specific patient populations. Through this approach, she defines patient data driven mechanisms of disease pathogenesis and identification of novel patient subsets, biomarkers and approaches to therapeutic discovery with disease target phenotyping and experimental validation. Dr. Peters also led the Disease Discovery group at Sema4, a patient centric health company since 2017. Prior to joining Mount Sinai, Dr. Peters was a scientist in oncology therapeutic discovery in the Cell Biology group at Imclone Systems, Eli Lilly and worked in business development at Regeneron. Dr. Peters has worked in Information Technology at Barclays and management consulting at Kaiser Associates where she advised Fortune 100 clients in the pharmaceutical, technology, consumer products, and aerospace and defense industries on business strategy.
Autoimmunity, Bioinformatics, Computational Biology, Drug Design and Discovery, Genomics, Immune Deficiency, Inflammation, Inflammatory Bowel Disease (IBD), Mucosal Immunology